ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

228
Analysis
Health Care • Japan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
bullish•Astellas Pharma
•31 Oct 2019 12:02

Astellas Pharma - Another Buyback

An hour ago, Astellas Pharma (4503 JP) announced a buyback for up to 32mm shares (around 1.7% of shares outstanding excluding Treasury shares) and...

Logo
497 Views
Share
bullish•LY
•03 Oct 2019 19:30

The BIG BUY of Z

18 months ago, Altaba Inc (AABA US) announced it would start selling down its 2bn shares-plus of Yahoo Japan - as of two days ago renamed Z...

Logo
1k Views
Share
•20 Dec 2018 05:24

Japan: The 2018-Q3 Cash Flow Stakes - Runners, Riders & Red Flags

JAPAN CORPORATE CASH FLOW UPDATE - This insight updates our previous Insight Yen Weakens > Normal Service Resumed with data from all of the...

Logo
926 Views
Share
•26 Nov 2018 09:09

Is It a Nikkei BOJ Squeeze on Nikkei 225 Low Float Names? Or Just FamilyMart Being FamilyMart?

A comment from a Smartkarma client prompted me to dig through this. It was an interesting comment suggesting the high weight Nikkei 225 names,...

Logo
810 Views
Share
bullish•Astellas Pharma
•31 Oct 2018 22:56

Astellas 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Key drivers including, Xtandi (up 17% to ¥164b) and Mirabegron (up 19% to ¥69b) drove overall sales up by 1% to ¥647b Favorable...

x